Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01557894
Other study ID # TTudor
Secondary ID
Status Completed
Phase N/A
First received March 15, 2012
Last updated September 5, 2014
Start date April 2012
Est. completion date March 2013

Study information

Verified date September 2014
Source Babes-Bolyai University
Contact n/a
Is FDA regulated No
Health authority Romania: Ethics Committee
Study type Interventional

Clinical Trial Summary

The main aim of this study is to investigate the effectiveness of an Internet-delivered intervention for social phobia by comparing it to a waitlist control group. The second aim of the study is to track the potential changes in participants' thinking patterns. Because this is among the first guided Internet-delivered interventions conducted in Romania, the treatment credibility will also be investigated. Finally, the predictive power of anxiety sensitivity for both SAD symptoms and the treatment effectiveness will be investigated.


Description:

The primary aim of this study is to investigate the effectiveness of an internet intervention for social phobia (i.e., the iSOFIE) by comparing it to a waitlist control group. iSOFIE was derived from a previously tested program (Furmark, Holmström, Sparthan, Carlbring, & Andersson, 2006) and has been significantly shortened while retaining the most important elements. The second aim of the study is to track the potential changes in participants' thinking patterns. While this intervention is primarily based on the cognitive-behavioral model of SAD (Clark and Wells, 1995), and no specific Rational Emotive Behavior Therapy (REBT, Ellis & Dryden, 1997) will be implemented, it is hypothesized that the cognitive restructuring and exposure exercises will make participants less prone to irrational thinking (as measured by the Attitude and Belief Scale-II (ABS-II, DiGiuseppe, Leaf, Exner, & Robin, 1988). To our knowledge, no study has investigated whether an iCBT program for SAD has the potential to alter participants' irrational thinking patterns. Moreover, because this is among the first guided Internet-delivered interventions conducted in Romania, the treatment credibility of the program will be investigated. Finally, the predictive power of anxiety sensitivity for both SAD symptoms and the treatment effectiveness will be investigated.


Recruitment information / eligibility

Status Completed
Enrollment 76
Est. completion date March 2013
Est. primary completion date March 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- over 18 years

- social anxiety disorder is the primary diagnostic (according to the DSM-IV)

- access to an Internet connected computer

- be fluent in Romanian language

Exclusion Criteria:

- suicidal ideation

- ongoing psychological treatment for social anxiety disorder

- recent change in psychiatric medication (i.e., during the last 6 weeks)

- psychoses or borderline personality disorder

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
iSOFIE
Cognitive - Behavioral: Internet-administrated CBT for social phobia that contains 9 self-help text modules and exercises (i.e., behavioral experiments)

Locations

Country Name City State
Romania Babes-Bolyai University Cluj - Napoca Cluj

Sponsors (2)

Lead Sponsor Collaborator
Babes-Bolyai University Linkoeping University

Country where clinical trial is conducted

Romania, 

References & Publications (1)

Tulbure BT, Månsson KN, Andersson G. Internet treatment for social anxiety disorder in Romania: study protocol for a randomized controlled trial. Trials. 2012 Oct 30;13:202. doi: 10.1186/1745-6215-13-202. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Leibowitz Social Anxiety Scale - Self Report (LSAS-SR) The Leibowitz Social Anxiety Scale - Self Report (LSAS-SR) measures social anxiety.
LSAS-SR presents 24 commonly anxiety-provoking situations, and asks participants to rate their fear and avoidance for each situation.
In order to obtain the total LSAS-SR score the Anxiety and Avoidance subscales scores are added together.
The LSAS-SR total score ranges from 0-144, with higher scores corresponding to greater social anxiety
pretreatment (week 0), post treatment (week 11), 6 month follow-up (week 37) No
Primary Social Phobia Inventory (SPIN) The Social Phobia Inventory (SPIN) is a brief (i.e., 17-item) self-report instrument measuring fear in social situations, avoidance of performance/social events, and physiological discomfort in social situations. Each item is rated on a 4-point scale.
Thus, for SPIN the range of scores is 0-68, with higher scores reflecting higher levels of social anxiety symptomatology
pretreatment (week 0), post treatment (week 11), 6 month follow-up (week 37) No
Secondary Beck Depression Inventory-II (BDI-II) Beck Depression Inventory-II (BDI-II) is a 21-item self-report inventory widely used to assess DSM-IV depressive symptoms. Each item consists of four statements, scored 0-3, indicating increasing symptom severity.
Thus, for BDI-II the range of scores is 0-63, with higher scores reflecting higher levels of depression.
pretreatment (week 0), post treatment (week 11), 6 month follow-up (week 37) No
Secondary Attitude and Belief Scale-II (ABS-II) The Attitude and Belief Scale-II (ABS-II) measures rational and irrational thinking as described by Albert Ellis. The scale was designed to capture four cognitive processes (i.e., demandingness, awfulizing, low frustration tolerance, and self-downing/global evaluation) in three content areas (i.e., achievement, approval, and comfort). We selected the 72-item ABS-II because preliminary psychometrics are available for the Romanian population.
The total ABS-II score range from 0 to 360, with higher scores corresponding to greater irrationality.
pretreatment (week 0), post treatment (week 11), 6 month follow-up (week 37) No
Secondary Anxiety Sensitivity Index (ASI) The Anxiety Sensitivity Index (ASI) is a 16-item questionnaire that measures the beliefs about the social and somatic consequences of anxiety symptoms. The total ASI score ranges from 0 to 64, with higher scores corresponding to greater anxiety sensitivity. pretreatment (week 0), post treatment (week 11), 6 month follow-up (week 37) No
See also
  Status Clinical Trial Phase
Completed NCT02590770 - Gaze Contingent Feedback in Social Anxiety Disorder N/A
Completed NCT00751465 - Dysfunctional Attention Processes in Fear of Blushing: Specificity and Changeability N/A
Completed NCT03630783 - Combined CBM For Social Anxiety in Turkey N/A
Terminated NCT00182533 - Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders Phase 4
Completed NCT01470469 - SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP) Phase 2
Not yet recruiting NCT05649059 - Investigating the Effects of Cannabidiol on Social Anxiety Disorder Phase 4